2 completed. 2 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Completed 2 |
Follow Hyper-IgM Immunodeficiency Syndrome: new trials by email Literature Review of Hyper-IgM Immunodeficiency Syndrome trials Research Report on Hyper-IgM Immunodeficiency Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency Gammaplex - Primary Immune Deficiency Disorders, Common Variable Immunodeficiency | Phase 4 | Completed | Bio Products Laboratory | 25 | 2011-03-01 | 2014-12-23 |
| Safety and Efficacy Study of Flebogamma 5% DIF IGIV in Pediatric Subjects Flebogamma 5% DIF - Primary Immune Deficiency Disease | Phase 4 | Completed | Instituto Grifols, S.A. | 24 | 2008-05-01 | 2017-02-02 |
Bruton type agammaglobulinemia (2) · Primary Immunodeficiency Diseases (2) · Wiskott-Aldrich Syndrome (2) · Bacterial Infections (1) · Common Variable Immunodeficiency (1)
Blood Coagulation Disorders (2) · Blood Coagulation Disorders, Inherited (2) · Blood Protein Disorders (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Cytopenia (2) · Dysgammaglobulinemia (2) · Genetic Diseases, Inborn (2) · Genetic Diseases, X-Linked (2) · Hematologic Diseases (2) · Hemic and Lymphatic Diseases (2) · Hemorrhagic Disorders (2) · Immune System Diseases (2) · Immunologic Deficiency Syndromes (2) · Leukocyte Disorders (2) · Leukopenia (2)
gamma-Globulins (2)
Bio Products Laboratory (1) · Instituto Grifols, S.A. (1)
United States (2) · Chile (1) · Israel (1)
Mark Ballow, MD (1) · Tim J. Aldwinckle, MD (1)